Using the three cytokines to trigger IBD-like conditions, the researchers examined whether a similar treatment of a commonly used cell line used to model IBD could produce a comparable response.

New basic science insights into programmed cell death could offer relief for inflammatory bowel disease. Subscribe to our ...

Inflammatory bowel disease (IBD) is an umbrella term for the inflammatory disorders Crohn's disease and ulcerative colitis..

--Organovo Holdings, Inc., a clinical stage biotechnology company that is focused on developing FXR314 in inflammatory bowel disease, including ulcerative colitis, based on demonstration of ...

I nflammatory bowel diseases (IBDs) such as ulcerative colitis and Crohn’s disease are syndromes caused by genetic and environmental factors that disrupt the intestinal immune responses. 1 Scientists ...

Inflammatory bowel disease, or IBD, is tough to treat, and existing therapies don’t work for everyone. Now, researchers have discovered a previously unknown link between a “master regulator ...

TEL AVIV, Israel, Jan. 23, 2023 (GLOBE NEWSWIRE) -- CytoReason, a leader and pioneer in computational disease modeling, today announced an expansion of its collaboration with Sanofi. The multiyear ...

In this retrospective study, researchers studied 25 patients who were treated with allogeneic hematopoietic stem cell transplant for monogenic IBD between 2012 and 2022. Prior to receiving stem cell ...

Building on the promise that stem cell transplantation offered as a curative approach for children with severe monogenic IBD—by resetting the immune system at its root—emerging drug delivery ...

TEL AVIV, Israel, Jan. 23, 2023 (GLOBE NEWSWIRE) -- CytoReason, a leader and pioneer in computational disease modeling, today announced an expansion of its collaboration with Sanofi. The multiyear ...

TEL AVIV, Israel, Jan. 23, 2023 (GLOBE NEWSWIRE) -- CytoReason, a leader and pioneer in computational disease modeling, today announced an expansion of its collaboration with Sanofi. The multiyear ...